LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00019435 · COMPLETED

Trial details

NCT number: NCT00019435
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Cancer Breast Cancer Colorectal Cancer Esophageal Cancer Gastric Cancer Lung Cancer Pancreatic Cancer

Start date: 1998-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.